ArticleCancer medicine2018

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro.

Yujin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.